Immunovant director Atul Pande sells common shares worth $108,000
IMVT•Immunovant director Atul Pande sold 3,000 common shares at $36 each on November 11, 2026, and exercised options for 3,000 shares at $8.43 each.
IMVT•IMVT•IMVT•Immunovant director Atul Pande sold 3,000 common shares at $36 each on November 11, 2026, and exercised options for 3,000 shares at $8.43 each.
After the transactions, Pande held 116,731 shares directly and another 20,000 indirectly through a trust. His remaining directly held options covered 62,181 shares and expire November 19, 2029.
